ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "Eye Disorders"

  • Abstract Number: 0432 • ACR Convergence 2025

    Frequency and Characteristics of Ophthalmologic Involvement in Patients with Rheumatoid Arthritis

    Javier Federico Flores Trejo1, Joan Manuel Dapeña2, Florencia Micaela Pascual3, Graciela Liliana Ghiglione1, Juan Manuel Bande3, María Alejandra Medina3, José Angel Caracciolo3 and Silvia Beatriz Papasidero3, 1Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina, 2Sanatorio Dr Julio Méndez, CABA, Ciudad Autonoma de Buenos Aires, Argentina, 3Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease that primarily affects synovial joints but may also involve extra-articular organs. Ocular involvement is one…
  • Abstract Number: 2701 • ACR Convergence 2025

    Ophthalmic Manifestations of Relapsing Polychondritis

    Akash Gupta1, Rennie Rhee2, Kaitlin Quinn3, Naomi Amudala2, Nirali Bhatt4, Carol McAlear2, Marcela ferrada5, Peter Grayson6, Peter Merkel2 and Shubhasree Banerjee2, 1Hospital of University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 4Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA, 5University of Maryland, Bethesda, MD, 6National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Chevy Chase, MD

    Background/Purpose: The prevalence of ocular involvement (OI) in patients with relapsing polychondritis (RP) has not been well defined. This study aimed to describe ocular manifestations,…
  • Abstract Number: 0507 • ACR Convergence 2025

    Diagnostic performance of the lacrimal and salivary gland ultrasound in patients with primary Sjogren’s disease of recent onset versus sicca controls.

    Rosa Elena Cervantes1, Carina Soto-Fajardo2, Fabian Carranza3, Gabriela Hernandez-Molina4, Narlly Ruíz Quintero5, Daniela Rojas Abarca6, Ana Mora7, Ada Rocío Morales Meza6, Carlos Montiel Castañeda8, Angela Maldonado Luna9, Fabiola Sánchez Zamudio6 and Carlos Pineda2, 1National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra"", Mexico City, Distrito Federal, Mexico, 2National Rehabilitation Institute " Luis Guillermo Ibarra Ibarra ", Mexico City, Mexico, 3National Rehabilitation Institute " Luis Guillermo Ibarra Ibarra ", Ciudad de México, Mexico, 4Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Federal District, Mexico, 5Instituto Nacional de Ciencias Medicas y Nutricion, México, city, Distrito Federal, Mexico, 6National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", Mexico, City, Distrito Federal, Mexico, 7National Rehabilitation Institute " Luis Guillermo Ibarra Ibarra ", Mexico, Mexico, 8National Institute of Rehabilitation "Luis Guillermo Ibarra Ibarra", México, city, Distrito Federal, Mexico, 9Instituto Nacional de Ciencias Medicas y Nutricion, Mexico, City, Estado de México, Mexico

    Background/Purpose: Sjögren's disease (SjD) is a chronic systemic autoimmune disease primarily affecting the exocrine glands. There is an increasing use of salivary gland ultrasound in…
  • Abstract Number: 0512 • ACR Convergence 2025

    Dry Eye Disease Severity and Salivary Gland Biopsy in Patients with Primary Sjögren’s Syndrome

    Karina Palomo-Arnaud1, Janett C. Riega-Torres2, Jose Martinez-Delgado3, Fernando Morales-Wong3, Jesus Mohamed-Hamsho3, Valeria Mata-Riega1, Irma Cantu-Zapata1, Luis Medina-Gomez1, Miguel Betancourt-De la Torre1, Aritze Chong-Amezcua1, Dionicio A. Galarza-Delgado4 and Karim Mohamed-Noriega3, 1Hospital Universitario "Dr. José Eleuterio González", Rheumatology, Monterrey, Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico, 3Hospital Universitario "Dr. José Eleuterio González", Ofthalmology, Monterrey, Nuevo León, Monterrey, Nuevo Leon, Mexico, 4Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Dry eye is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film. This is commonly observed…
  • Abstract Number: 0537 • ACR Convergence 2025

    HLA-B27 and Axial Involvement as Independent Risk Factors for Uveitis in Spondyloarthritis: New Insights from a 15-Year Real-Life Study

    Kent LE1, Hervé LOCRELLE1, Myriam NORMAND1, Irina COMAN1, Louis DELENTE1, Tiphany NEEL1, Adamah AMOUZOUGAN1, Thierry THOMAS1 and Hubert Marotte2, 1Service Rhumatologie Hôpital Nord, Saint-Etienne, France, 2INSERM 1059/University of Saint-Etienne, Saint-Etienne, France

    Background/Purpose: To assess the prevalence, risk factors and treatment-related outcomes of uveitis in patients with spondyloarthritis (SpA), using data from a 15-year real-life cohort.Methods: We…
  • Abstract Number: 0888 • ACR Convergence 2025

    TargetScan Platform Identifies Targets of CD8+ T cells in Ankylosing Spondylitis and Birdshot Uveitis

    Adam S. Weinheimer1, Olivia Pryor2, Catalina Burbano3, Tyler Heath3, Livio Dukaj3, Shoshana M.K. Bloom3, Jackson Lirette3, Rachel Lent3, Prachi Dhanania3, Nicole A. Ladd3, Ryan Kritzer3, Hana Husic3, Shobitha Jillella3, Alexander Cristofaro2, Chandan K. Pavuluri3, Jenna LaBelle3, Laurie Barefoot3, Shrikanta Chattopadhyay3, Andrew P. Ferretti3 and Cagan Gurer3, 1TScan Therapeutics, Boston, MA, 2TScan Therapeutics, Waltham, 3TScan Therapeutics, Waltham, MA

    Background/Purpose: Antigen-specific therapies offer a promising approach to selectively modulating autoimmune responses without broad immunosuppression. Strong associations with specific Class I HLA alleles in ankylosing…
  • Abstract Number: 0708 • ACR Convergence 2025

    Association Of Choroidal Sub-foveal Thickness With Skin Manifestations And Serum Monocyte HDL Ratio In Patients With Systemic Sclerosis-A Case Control Study

    Tejaswini Ramineni1, Vijaya prasanna Parimi2, Radhika M3 and Narsimulu Gumdal3, 1Esic Medical College And Hospital, Sanathnagar, Hyderabad, Telangana, India, 2ESIC Medical College and Super Specilaity Hospital, hyderabad, Telangana, India, 3ESIC MEDICAL COLLEGE AND HOSPITAL, Hyderabad, Telangana, India

    Background/Purpose: The vascular hypothesis in systemic sclerosis (SSc) posits that vasculopathy is the initial inciting event that triggers inflammation and subsequent fibrosis in the progression…
  • Abstract Number: 1106 • ACR Convergence 2025

    Faster Ellipsoid Zone Loss in Hydroxychloroquine Retinopathy with Tapering versus Discontinuation: A Longitudinal Optical Coherence Tomography Study from a Single Center in Taiwan

    Ko-Jen Li1, Ting-Wei Chang2, Tso-Ting Lai3, Jui-Hung Kao4, TING-YUAN LAN5, Tai-Ju Lee6, pei-Hsinq lai7, Shao-Yu Pai8, Chiehyu Shen9 and Song-Chou Hsieh10, 1National Taiwan University Hospital, Taipei, Taiwan, 2National Taiwan University Hospital Hsinchu Branch, Taichung, Taiwan, 3Naitional Taiwan University Hospital, Taipei, Taiwan (Republic of China), 4Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, Taipei, Taiwan (Republic of China), 5National Taiwan University Hospital Hsinchu Branch, Hsinchu City, Taiwan, 6National Taiwan University Hospital Hsinchu Branch, Hsinchu City, Taiwan (Republic of China), 7Taipei City Hospital, Taichung, Taiwan, 8National Taiwan University Hospital, Taichung City, Taiwan (Republic of China), 9National Taiwan University Hospital, Taipei city, Taiwan, 10National Taiwan Unuversity Hospital, Taipei City, Taiwan (Republic of China)

    Background/Purpose: Hydroxychloroquine (HCQ) retinopathy is a progressive, vision-threatening retinal disease. While HCQ is typically discontinued after toxicity is detected, some patients undergo tapering due to…
  • Abstract Number: 0264 • ACR Convergence 2025

    Seeing Beyond the Eye: Subclinical Audio-Vestibular Involvement in Vogt-Koyanagi-Harada Disease

    Mohamed Tharwat Hegazy, Rania Yacoub, Sarah Sheta, Rana Hussein Amin and Noha Khalil, Faculty of Medicine, Cairo University, Cairo, Egypt

    Background/Purpose: Vogt-Koyanagi-Harada disease (VKH) is a systemic disease that affects the central nervous system, ocular, and integumentary system. It causes bilateral granulomatous uveitis, dysacusia ranging…
  • Abstract Number: 1389 • ACR Convergence 2025

    Association Of Dry Eye Severity With Salivary Flow In Patients With Primary Sjögren’s Syndrome

    Janett C. Riega-Torres1, Karina Palomo-Arnaud2, Jose Martinez-Delgado3, Fernando Morales-Wong3, Jesus Mohamed-Hamsho3, Valeria Mata-Riega2, Irma Cantu-Zapata2, Luis Medina-Gomez2, Miguel Betancourt-De la Torre2, Aritze Chong-Amezcua2, Dionicio A. Galarza-Delgado4 and Karim Mohamed-Noriega3, 1Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico, 2Hospital Universitario "Dr. José Eleuterio González", Rheumatology, Monterrey, Nuevo León, Monterrey, Nuevo Leon, Mexico, 3Hospital Universitario "Dr. José Eleuterio González", Ofthalmology, Monterrey, Nuevo León, Monterrey, Nuevo Leon, Mexico, 4Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Sjögren’s Syndrome (SS) is a multisystemic autoimmune disease that causes hypofunction of salivary and lacrimal glands, manifesting in xerostomia and xerophthalmia among other systemic…
  • Abstract Number: 0268 • ACR Convergence 2025

    Multicenter study and literature review of JAK inhibitor treatment in refractory uveitis due to different immune-mediated inflammatory pathologies

    Nuria Barroso Garcia1, Lara Sánchez Bilbao2, José Luis Martín-Varillas3, Vanesa Calvo-Río2, Mar Esteban Ortega4, Santiago muñoz Fernández5, José Luis Álvarez-Vega6, Emma Beltran7, Vega Jovaní8, Olga Maiz Alonso9, raúl Veroz González10, Angel Garcia-Aparicio11, marta Garijo Bufort12 and Ricardo Blanco2, 1Rheumatology, Hospital Regional Universitario, Universidad de Málaga UMA, Málaga, Spain, Malaga, Spain, 2Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 3Rheumatology Division, Hospital de Laredo. IDIVAL, Immunopathology Group. Santander, Spain., Laredo, Spain, 4Rheumatology and Ophthalmology. Hospital Infanta Sofía. Madrid. Spain, Madrid, Spain, 5Rheumatology and Ophthalmology. Hospital Infanta Sofía, Madrid. Spain, Madrid, 6Rheumatology. Complejo Hospitalario Universitario de Badajoz, Badajoz, Spain., Badajoz, Spain, 7Rheumatology. Hospital del Mar. Barcelona, Spain., Barcelona, Spain, 8Hospital General Universitario de Alicante, Reumatología, Alicante, Alicante, Comunidad Valenciana, Spain, 9Rheumatology. Hospital de Donostia. San Sebastián, Spain., San Sebastián, Spain, 10Rheumatology. Hospital de Mérida. Mérida, Spain., Mérida, Spain, 11Hospital Universitario de Toledo, Toledo, Spain, 12Rheumatology Department, Hospital de Sagunto, Spain, Valencia, Spain

    Background/Purpose: Non-infectious uveitis may be related to several immune-mediated diseases (IMIDs). Those that are refractory to conventional therapy or biologics may lead to severe ocular…
  • Abstract Number: 1665 • ACR Convergence 2025

    Comparative Effectiveness of Biologic Versus Conventional Therapy in Uveitis with Systemic Rheumatic Diseases: Real-World Evidence from a Propensity-Matched Cohort

    Hanieh Akbari1 and shahrzad Abdollahi2, 1Jefferson Einstein Montgomery Medical Center, Norristown, PA, 2Jefferson Einstein Philadelpha, Philadelphia, PA

    Background/Purpose: Uveitis is a vision-threatening manifestation of systemic rheumatic diseases. While conventional immunosuppressants are typically first-line, biologics are often reserved for refractory cases. Long-term real-world…
  • Abstract Number: 0394 • ACR Convergence 2025

    Predictors of quality of Life in a longitudinal cohort of patients with Uveitis, Juvenile Idiopathic Arthritis, and JIA-associated uveitis

    andressa Guariento Ferreira Alves1, Amy Cassedy2, Virginia Miraldi Utz3, Alexandra Duell3, Megan Quinlan-Waters4, Nicole Reitz5, Sheila Angeles-Han6 and Melissa Lerman7, 1The Children's Hospital of Philadelphia, Philadelphia, PA, 2Cincinnati Children's hospital medical center, cincinnati, OH, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Cincinnati Children's Hospital Medical Center, CCHMC, 5Department of Mental Health, St. Louis, MO, 6Cincinnati Children's Hospital, Cincinnati, OH, 7Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Uveitis, juvenile idiopathic arthritis (JIA), and JIA-associated uveitis (JIA-U) greatly influence children's quality of life (QOL). Our aim is to identify demographic, disease, and…
  • Abstract Number: 1722 • ACR Convergence 2025

    Defining Safe Hydroxychloroquine Blood Levels: Time to Switch to Precision Monitoring for Optimized Lupus Care

    Shivani Garg1, Benoit Blanchet2, Yann Nguyen3, Fauzia Hollnagel4, Ada Clarke5, Michelle Petri6, Murray Urowitz7, John Hanly8, Caroline Gordon9, Sang-Cheol Bae10, Juanita Romero-Diaz11, Jorge Sanchez-Guerrero12, Ann Clarke13, Sasha Bernatsky14, Daniel Wallace15, David A. Isenberg16, Anisur Rahman16, Joan Merrill17, Paul Fortin18, Dafna D. Gladman19, Ian Bruce20, Ellen Ginzler21, Mary Anne Dooley22, Rosalind Ramsey-Goldman23, Susan Manzi24, Andreas Jönsen25, Graciela Alarcón26, Ronald van Vollenhoven27, Cynthia Aranow28, Murat Inanc29, Meghan mackay30, Guillermo Ruiz-Irastorza31, S. Sam Lim32, Murat Inac33, Kenneth Kalunian34, Søren Jacobsen35, Christine Peschken11, Diane Kamen36, Anca Askanase37, Jill Buyon38, Julie Chezel5, Alicja Puszkiel39 and Nathalie Costedoat-Chalumeau40, 1University of Madison, School of Medicine and Public Health, Madison, WI, 2National Referral Centre for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, Paris, France, 3Department of Internal Medicine, Beaujon Hospital, AP-HP Nord, Université Paris Cité, Clichy, France, Clichy, France, 4University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 5Cochin Hospital, Paris, France, 6Johns Hopkins University School of Medicine, Timonium, MD, 7University of Toronto, Toronto, ON, Canada, 8Dalhousie University, Halifax, NS, Canada, Halifax, NS, Canada, 9Department of Inflammation and Ageing, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom, 10Hanyang University Medical Center, Seoul, South Korea, 11University of Manitoba, Winnipeg, MB, Canada, 12Mount Sinai Hospital and University Health Network, Toronto, Canada, 13Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 14Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 15Cedars Sinai Medical Center, Studio City, CA, 16University College London, London, United Kingdom, 17Oklahoma Medical Research Foundation, Oklahoma, 18Centre ARThrite - CHU de Québec - Université Laval, Quebec, QC, Canada, 19Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Division of Rheumatology, Toronto, ON, Canada, 20Centre for Public Health, Faculty of Medicine, Health and Life Sciences, Queen’s University Belfast, Belfast, United Kingdom, 21SUNY Downstate Health Sciences University, New York, NY, 22UNC physician network, Chapel Hill, NC, 23Northwestern University Feinberg School of Medicine, Chicago, IL, 24Lupus Center of Excellence, Autoimmunity Institute, Allegheny Health Network, Pittsburgh, PA, 25Department of Clinical Sciences, Lund University, Lund, Sweden, 26The University of Alabama at Birmingham, Oakland, CA, 27Department of Rheumatology, Amsterdam University Medical Centre, Amsterdam, Netherlands, 28Institute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 29Istanbul University, Istanbul, Turkey, 30Feinstein Institutes for Medical Research, Manhasset, NY, 31Biobizkaia Health Research Institute, Barakaldo, Spain, 32Emory University School of Medicine, Atlanta, GA, 33Istanbul University, Istanbul, 34UC San Diego, La Jolla, CA, 35Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, 36Medical University of South Carolina, Johns Island, SC, 37Columbia University Medical Center, New York, NY, 38NYU Grossman School of Medicine, New York, NY, 39Cochin Hospital, Paris, 40Inserm DR Paris 5, Paris, France

    Background/Purpose: Current guidelines recommend using hydroxychloroquine (HCQ) dose ≤5.0 mg/kg for managing SLE. However, 6-fold higher SLE flares, including those requiring hospitalizations, are noted with…
  • Abstract Number: 0396 • ACR Convergence 2025

    Quantifying Burden of Uveitis Care for Pediatric Uveitis Patients and Caregivers

    Catherine Lavallee1, Samuel Garfinkle2, Devlin Eckardt3, Stefanie Davidson4, Melissa Lerman5, Nicole Reitz6 and Kerry Hurlbut5, 1St. Christopher's Hospital for Children, Philadelphia, PA, 2Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 3Children's Hospital of Philadelphia, Philadelphia, 4University of Pennsylvania/CHOP, Philadelphia, PA, 5Children's Hospital of Philadelphia, Philadelphia, PA, 6Department of Mental Health, St. Louis, MO

    Background/Purpose: Chronic noninfectious uveitis (CU) in pediatric patients is often asymptomatic and can cause vision loss, requiring frequent ophthalmologist visits and long-term treatment. This survey…
  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10
  • Next Page

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology